Search

everythinglearnresearchcommunity

for

Search:↓

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

New methods improve how we test hair growth treatments, but challenges like slow hair changes and high costs remain.

PRP injections may be a safe, effective alternative for hair loss treatment compared to minoxidil and finasteride.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Hair loss links to higher death risk from diabetes and heart disease; not a direct cause, but a marker for risk factors.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Hair loss treatments include medications and new methods like low-level light therapy, which may work by boosting cell activity and blood flow.

Trichoscopy is better than trichogram for diagnosing female hair loss.

AR/EDA2R gene linked to early-onset female hair loss, but 20p11 gene not involved.

Female hair loss linked to metabolic syndrome, not in males.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Scalp dermatoscopy helps diagnose and monitor hair loss severity.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

Women with androgenetic alopecia experience worse physical well-being and quality of life, but similar mental health compared to those without it.

Acne severity in women may not be linked to increased male hormone indicators like excess body hair, menstrual irregularities, or hair loss.

Overweight smokers have worse hair loss.

Metabolic syndrome linked to female hair loss; waist size and high blood pressure important factors.

AGA increased yearly, type I most common, and family history and seborrheic dermatitis often linked.

FDG PET/CT scans can change cancer treatment plans for dogs.

The BASP classification is more reliable than the Norwood-Hamilton for classifying hair loss in men and women.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Oral contraceptives may cause hair loss in women.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Oral minoxidil improves hair density in women with androgenetic alopecia, with mild side effects.

Various treatments exist for hair loss, but more research is needed for better options.

Hair restoration surgery has improved with better techniques for natural looks and managing patient expectations, but it remains labor-intensive and requires careful consideration of potential complications.

The article concludes that different types of hair loss require specific treatments and psychological support is important.

Women with female pattern hair loss may have a higher risk of developing metabolic syndrome.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.